CytomX Therapeutics (CTMX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $165.1 million.
- CytomX Therapeutics' Shares Outstanding rose 11099.85% to $165.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.1 million, marking a year-over-year increase of 11099.85%. This contributed to the annual value of $80.1 million for FY2024, which is 1900.0% up from last year.
- Per CytomX Therapeutics' latest filing, its Shares Outstanding stood at $165.1 million for Q3 2025, which was up 11099.85% from $164.9 million recorded in Q2 2025.
- CytomX Therapeutics' 5-year Shares Outstanding high stood at $165.1 million for Q3 2025, and its period low was $65.0 million during Q1 2021.
- Over the past 5 years, CytomX Therapeutics' median Shares Outstanding value was $66.8 million (recorded in 2023), while the average stood at $79.3 million.
- Per our database at Business Quant, CytomX Therapeutics' Shares Outstanding surged by 60.84% in 2022 and then skyrocketed by 11110.62% in 2025.
- Quarter analysis of 5 years shows CytomX Therapeutics' Shares Outstanding stood at $65.4 million in 2021, then grew by 1.28% to $66.2 million in 2022, then grew by 1.63% to $67.3 million in 2023, then increased by 19.0% to $80.1 million in 2024, then soared by 106.08% to $165.1 million in 2025.
- Its Shares Outstanding was $165.1 million in Q3 2025, compared to $164.9 million in Q2 2025 and $80.6 million in Q1 2025.